MSD’s checkpoint inhibitor Keytruda has been cleared by the FDA for use in newly diagnosed cervical cancer patients with less severe disease, becoming the first anti-PD-1/PD-L1 immunotherapy for ...

Merck & Co's FDA approval for Keytruda in advanced liver cancer looks secure, after an Asian clinical trial found that the cancer immunotherapy improved survival in these patients. Keytruda ...

The Company is nearing conclusion of monotherapy dose escalation which is now at the 665 mg once weekly IV dose ... PRT3789 in combination with KEYTRUDA® (pembrolizumab) in patients with SMARCA4 ...

The Company is nearing conclusion of monotherapy dose escalation which is now at the 665 mg once weekly IV dose ... PRT3789 in combination with KEYTRUDA® (pembrolizumab) in patients with SMARCA4 ...

Immunotherapy advances in triple-negative breast cancer drive personalized treatments with immune checkpoint inhibitors, aiding subtype identification and new combination therapy developments.

bubbling under hot 100 the week’s most popular current songs across all genres below no. 100, ranked by streaming activity data by online music sources tracked by luminate, radio airplay ...

Send us a tip using our anonymous form. A daily briefing on what matters in the music industry ...

Cintas Corp. $192.21-4.35-2.21% ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Combining data, computation, and inferential thinking, data science is redefining how people and organizations solve challenging problems and understand their world. This intermediate-level class ...